l-DOPA生产的新兴策略:整合植物,化学,酶和微生物策略
Mengzhen Jia1, Jiaying Pei1, Feilong Chen2
1College of Bioscience and Bioengineering, Jiangxi Engineering Laboratory for the Development and Utilization of Agricultural Microbial Resources, Jiangxi Agricultural University, Nanchang 330045, China.
ACS synthetic biology
|February 19, 2026
概括
使用代谢工程的微生物发酵为生产l-3,4-Dihydroxyphenylalanine (l-DOPA) 提供了一种可持续的方法. 这种方法提高了产量,并降低了这种必要的治疗方法的成本.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 生物制造 生物制造 生物制造
背景情况:
- l-3,4-二基氨酸 (l-DOPA) 是一种关键的治疗药物,但传统的生产方法 (植物提取,化学合成) 是低效和环境负担.
- 酶和全细胞生物催化剂有希望,但受酶稳定性的限制.
- 微生物发酵为l-DOPA生物合成提供了一个可扩展,可持续的替代方案.
研究的目的:
- 审查l-DOPA生物制造的最新进展.
- 突出代谢工程策略,以改善l-DOPA的生产.
- 讨论微生物发酵在可持续治疗生产中的潜力.
主要方法:
- 途径的重建和放松调节,以增强生物合成.
- 优化前体供应和碳流量.
- 删除竞争中的代谢途径.
- 为提高效率,Shikimate的路径工程.
主要成果:
- 在工程微生物中的l-DOPA生产标位显著改善.
- 开发用于直接l-DOPA生物合成的代谢工程菌株.
- 在微生物发酵中展示了高特异性和可扩展性.
结论:
- 微生物发酵的代谢工程是可持续的l-DOPA生产的强大平台.
- 进步正在为成本效益和环保的l-DOPA制造铺平道路.
- 这种方法支持开发下一代神经退行性疾病治疗方法.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Organic Acids
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...


